Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06852794

USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC

The present study aims to evaluate the usefulness of artificial intelligence (AI) in the back-office of an ILD (Interstitial Lung Disease) clinic.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Interstitial Disease

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients attending ILD clinic of the IRCCS Fondazione Policlinico A. Gemelli.

Exclusion criteria

  • Patients unable or unwilling to sign the informed consent
  • Patients who are senders of one of the emails chosen for the questionnaire
  • Patients with manifest inability to fill out the questionnaire

Treatment and study plan

Survey

Other

The patients will receive questionnaires. The enrolled patients will be asked to provide feedback on the answers they read.

Primary outcomes

  1. Variation of VAS scores of clarity of the message in questionnaires administered at T1 and at T2

    Time frame: 15 days

  2. Variation of VAS scores of empathy conveyed in questionnaires administered at T1 and at T2

    Time frame: 15 days

Secondary outcomes

  1. Percentage of answers recognised correctly as answers provided by AI among the total of answers flagged as provided by AI by study subjects

    Time frame: 1 day

  2. Stratify the results by patients' demographic characteristics and past experiences with artificial intelligence systems.

    Time frame: 1 day

Study contacts

Contact information is provided by the study sponsor or research team.

Diana Verdirosi, Sc

CONTACT

[email protected]

+390630157724

Luca Richeldi, MD

CONTACT

[email protected]

+390630157857

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Official study title

USE OF ARTIFICIAL INTELLIGENCE IN THE BACK-OFFICE OF A SPECIALIZED MEDICAL CLINIC FOR PULMONARY FIBROSIS (LLM-ILD)

Acronym: LLM-ILD

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Feb 28, 2025
Registry last updated
Feb 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.